FindTrial
Sign In

Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Evaluation of Intradermal Exosome Injection in Treatment of Male Androgenetic Alopecia: A Clinical and Immunohistochemical Study

Status
Not yet recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07112586
Enrollment
15
Registered
2025-08-08
Start date
2025-08-30
Completion date
2027-01-31
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic Alopecia

Keywords

Androgenetic Alopecia

Brief summary

Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker

Interventions

DRUGPlasma derived exosomes

Exosomes derived from patients' plasma, centrifuged at high speeds multiple times

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

\- Androgenetic Alopecia Grades 1-4

Exclusion criteria

* blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes

Design outcomes

Primary

MeasureTime frameDescription
Terminal to vellus hair ratio improvementOne yearCounting the terminal and vellus hair counts and calculating the ratio, and comparing it between different study sessions and at follow-ups

Countries

Egypt

Contacts

Primary ContactDana Ashraf Maher, Assistant lecturer
dana.maher1@outlook.com+20 1225077011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026